181 related articles for article (PubMed ID: 36478348)
1. Localization of Fusobacterium nucleatum in oral squamous cell carcinoma and its possible directly interacting protein molecules: A case series.
He X; Ma X; Meng Z; Han Z; Chen W
Histol Histopathol; 2023 Aug; 38(8):929-939. PubMed ID: 36478348
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol is an inhibitory polyphenol of epithelial-mesenchymal transition induced by Fusobacterium nucleatum.
Min J; Mashimo C; Nambu T; Maruyama H; Takigawa H; Okinaga T
Arch Oral Biol; 2024 Apr; 160():105897. PubMed ID: 38290225
[TBL] [Abstract][Full Text] [Related]
3. The prevalence rate of periodontal pathogens and its association with oral squamous cell carcinoma.
Chang C; Geng F; Shi X; Li Y; Zhang X; Zhao X; Pan Y
Appl Microbiol Biotechnol; 2019 Feb; 103(3):1393-1404. PubMed ID: 30470868
[TBL] [Abstract][Full Text] [Related]
4. Fusobacterium nucleatum impairs DNA mismatch repair and stability in patients with squamous cell carcinoma of the head and neck.
Hsueh CY; Lau HC; Huang Q; Gong H; Sun J; Cao P; Hu C; Zhang M; Tao L; Zhou L
Cancer; 2022 Sep; 128(17):3170-3184. PubMed ID: 35789992
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of intratumoral Fusobacterium nucleatum and association with immune-related gene expression in oral squamous cell carcinoma patients.
Neuzillet C; Marchais M; Vacher S; Hilmi M; Schnitzler A; Meseure D; Leclere R; Lecerf C; Dubot C; Jeannot E; Klijanienko J; Mariani O; Calugaru V; Hoffmann C; Lesnik M; Badois N; Borcoman E; Piaggio E; Kamal M; Le Tourneau C; Bieche I
Sci Rep; 2021 Apr; 11(1):7870. PubMed ID: 33846399
[TBL] [Abstract][Full Text] [Related]
6. Epithelial-mesenchymal transition (EMT) markers have prognostic impact in multiple primary oral squamous cell carcinoma.
da Silva SD; Morand GB; Alobaid FA; Hier MP; Mlynarek AM; Alaoui-Jamali MA; Kowalski LP
Clin Exp Metastasis; 2015 Jan; 32(1):55-63. PubMed ID: 25433796
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Microbial Distribution in Different Oral Niches of Oral Squamous Cell Carcinoma.
Nie F; Wang L; Huang Y; Yang P; Gong P; Feng Q; Yang C
Front Cell Infect Microbiol; 2022; 12():905653. PubMed ID: 36046741
[TBL] [Abstract][Full Text] [Related]
8. A Plausible Proposition of CCL20-Related Mechanism in
Mandal DP; Mohanty N; Behera PK; Gopinath D; Panda S; Al-Kheraif AA; Divakar DD; Anil S; Panda S
Life (Basel); 2021 Nov; 11(11):. PubMed ID: 34833094
[TBL] [Abstract][Full Text] [Related]
9. The Oral Microbiota May Have Influence on Oral Cancer.
Zhang L; Liu Y; Zheng HJ; Zhang CP
Front Cell Infect Microbiol; 2019; 9():476. PubMed ID: 32010645
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of Epithelial Mesenchymal Transition Proteins E-Cadherin, β-Catenin, and N-Cadherin in Oral Squamous Cell Carcinoma.
Angadi PV; Patil PV; Angadi V; Mane D; Shekar S; Hallikerimath S; Kale AD; Kardesai SG
Int J Surg Pathol; 2016 Dec; 24(8):696-703. PubMed ID: 27312520
[TBL] [Abstract][Full Text] [Related]
11. Siah-1 is associated with expression of hypoxia-inducible factor-1α in oral squamous cell carcinoma.
Aga M; Kondo S; Wakisaka N; Moriyama-Kita M; Endo K; Nakanishi Y; Murono S; Sugimoto H; Ueno T; Yoshizaki T
Auris Nasus Larynx; 2017 Apr; 44(2):213-219. PubMed ID: 27616748
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical assessment of E-cadherin and β-catenin in the histological differentiations of oral squamous cell carcinoma.
Zaid KW
Asian Pac J Cancer Prev; 2014; 15(20):8847-53. PubMed ID: 25374218
[TBL] [Abstract][Full Text] [Related]
13. [Expression levels of MMP-14, ING4 and HIF-1α in 60 patients with oral squamous cell carcinoma and their clinical significance].
Fu ZY; Tao F
Shanghai Kou Qiang Yi Xue; 2020 Dec; 29(6):642-646. PubMed ID: 33778834
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
15. Fusobacterium nucleatum promotes esophageal squamous cell carcinoma progression via the NOD1/RIPK2/NF-κB pathway.
Nomoto D; Baba Y; Liu Y; Tsutsuki H; Okadome K; Harada K; Ishimoto T; Iwatsuki M; Iwagami S; Miyamoto Y; Yoshida N; Watanabe M; Moroishi T; Komohara Y; Sawa T; Baba H
Cancer Lett; 2022 Apr; 530():59-67. PubMed ID: 35033591
[TBL] [Abstract][Full Text] [Related]
16. Conversion from epithelial to partial-EMT phenotype by Fusobacterium nucleatum infection promotes invasion of oral cancer cells.
Shao W; Fujiwara N; Mouri Y; Kisoda S; Yoshida K; Yoshida K; Yumoto H; Ozaki K; Ishimaru N; Kudo Y
Sci Rep; 2021 Jul; 11(1):14943. PubMed ID: 34294795
[TBL] [Abstract][Full Text] [Related]
17. MiR-524 suppressed the progression of oral squamous cell carcinoma by suppressing Metadherin and NF-κB signaling pathway in OSCC cell lines.
Chang XS; Zhu J; Yang T; Gao Y
Arch Oral Biol; 2021 May; 125():105090. PubMed ID: 33676362
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-18a regulates the metastatic properties of oral squamous cell carcinoma cells via HIF-1α expression.
Kim S; Park S; Oh JH; Lee SS; Lee Y; Choi J
BMC Oral Health; 2022 Sep; 22(1):378. PubMed ID: 36064348
[TBL] [Abstract][Full Text] [Related]
19. Convergent dysbiosis of upper aerodigestive microbiota between patients with esophageal and oral cavity squamous cell carcinoma.
Zhu H; Yip HC; Cheung MK; Chan HC; Ng C; Lau EHL; Yeung ZWC; Wong EWY; Leung L; Qu X; Wang D; Cai L; Chan PKS; Chan JYK; Chen Z
Int J Cancer; 2023 May; 152(9):1903-1915. PubMed ID: 36752573
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of Akt activity induces the mesenchymal-to-epithelial reverting transition with restoring E-cadherin expression in KB and KOSCC-25B oral squamous cell carcinoma cells.
Hong KO; Kim JH; Hong JS; Yoon HJ; Lee JI; Hong SP; Hong SD
J Exp Clin Cancer Res; 2009 Feb; 28(1):28. PubMed ID: 19243631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
